Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PRTA
#2844
Prothena Corporation plc Ordinary Shares
10.5
6
USD
+2.42%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.42%
Monthly Change
+13.92%
6 month change
+4.35%
Year Change
+6.77%
Previous Close
10.3
1
Open
10.3
4
Bid
Ask
Low
10.3
4
High
10.5
6
Volume
21
Markets
US Stock Market
Healthcare
PRTA
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
39.99 M
46.69 M
52.56 M
53.72 M
53.83 M
53.83 M
—
Valuation ratios
Enterprise value
184.87 M
1.73 B
2.1 B
1.45 B
274.12 M
206.57 M
604.6 M
Price to earnings ratio
—
35.8
-21.66
-13.96
-6.1
-2.11
-11.11
Price to sales ratio
—
11.93
42.06
16.76
4.63
21.58
54.79
Price to cash flow ratio
—
25.85
-23.29
-15.32
-4.96
-3.14
-12.72
Price to book ratio
—
5.14
4.07
3.65
1.53
1.83
2.68
Enterprise value to EBITDA ratio
-1.68
23.62
-16.89
-9.12
-2.14
-1.03
-3.85
Profitability ratios
Return on assets %
-0.33
0.11
-0.15
-0.21
-0.22
-0.75
-0.61
Return on equity %
-0.6
0.14
-0.19
-0.26
-0.25
-0.87
-0.73
Return on invested capital %
-891.51
572.42
-866.74
-977.67
-721.49
-1 703.4
-1 546.73
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-5 073.54
35.88
-218.34
-156.1
-96.02
-900.98
-3 549.42
EBITDA margin %
-4 943.79
36.45
-206.57
-130
-79.42
-837.87
-3 267.32
Net margin %
-5 001.98
33.38
-194.09
-120.14
-75.98
-1 024.61
-3 813.19
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
11.58
17.48
14.34
11.24
10.01
7.72
29.01
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.43
0.09
0.17
0.26
0.05
0.06
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
1.91
-2.3
-2.52
-2.79
-3.04
-3.04
EBIT per share
—
1.49
-2.64
-3.01
-2.39
-3.72
-3.72
EBITDA per share
—
1.51
-2.63
-2.99
-2.38
-3.71
-3.71
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
11.95
15
11.63
8.77
5.71
26.52
Net current asset value per share
—
12.07
15.18
12.01
9.03
5.86
27.44
Tangible book value per share
—
9.62
13.13
10.55
9.06
5.21
24.85
Working capital per share
—
11.38
14.12
10.94
8.13
5.1
23.56
Book value per share
—
9.62
13.13
10.55
9.06
5.21
24.85
News
AZN Posts Data From Hypophosphatasia Program on Efzimfotase Alfa
Sanofi Gets EU Nod for Rezurock in Chronic Graft-Vs-Host Disease
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease
Why Is Sarepta Therapeutics (SRPT) Up 24.2% Since Last Earnings Report?
Why Is Jazz (JAZZ) Down 3.9% Since Last Earnings Report?
Citizens reaffirms Prothena stock rating on Novo Nordisk milestone
Prothena earns $50M milestone from Novo Nordisk for drug trial
Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to Trade
Prothena stock jumps on $100M share buyback authorization
Prothena authorizes $100 million share buyback program
Prothena Q4 Earnings Meet Estimates, Pipeline Progress in Focus
Prothena Corporation plc (PRTA) Q4 2025 Earnings Call Transcript